Kyntra Bio, Inc.
USD6.81
-0.03 (-0.44%)
CEO
Thane Wettig
IPO Date
2014-11-14
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$6.79
Prev. Close
$6.84
Day Low
$6.79
Day High
$6.93
52W Low
$4.85
52W High
$12.60
Market Cap
$0.03B
Volume
0.01M
| 2,800 |
| $7.09 |
| 10 Mar 2026 | Wettig Thane | director, officer: CEO | F-InKind | Disposed | 277 | $6.84 |
| 10 Mar 2026 | DeLucia David | Chief Financial Officer | F-InKind | Disposed | 60 | $6.84 |
| 5 Feb 2026 | Wettig Thane | director, officer: CEO | A-Award | Acquired | 60,000 | $8.50 |
| 5 Feb 2026 | DeLucia David | Chief Financial Officer | A-Award | Acquired | 26,000 | $8.50 |
| 9 Dec 2025 | DeLucia David | Chief Financial Officer | F-InKind | Disposed | 52 | $8.42 |
| 9 Dec 2025 | Wettig Thane | director, officer: CEO | F-InKind | Disposed | 259 | $8.42 |
| 17 Nov 2025 | Wettig Thane | director, officer: CEO | P-Purchase | Acquired | 1,000 | $9.18 |
| 17 Nov 2025 | Wettig Thane | director, officer: CEO | P-Purchase | Acquired | 2,700 | $9.10 |